NCT07746687 — "A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma" trial site landscape

Public-registry site landscape for NCT07746687, “A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma”, a Asthma study sponsored by Janssen Research & Development, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07746687 (registry record)
Study title	A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
Official title	A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Inadequately Controlled Moderate to Severe Asthma
Sponsor	Janssen Research & Development, LLC
Condition(s)	Asthma
Phase	PHASE2
Listed sites	0

Patient-friendly overview of this study: eichor.com/study/NCT07746687.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07746687 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →